0000899243-19-002190.txt : 20190130
0000899243-19-002190.hdr.sgml : 20190130
20190130160701
ACCESSION NUMBER: 0000899243-19-002190
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190128
FILED AS OF DATE: 20190130
DATE AS OF CHANGE: 20190130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mobasher Mehrdad
CENTRAL INDEX KEY: 0001765484
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 19552005
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-28
0
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001765484
Mobasher Mehrdad
CORVUS PHARMACEUTICALS, INC.
863 MITTEN ROAD, SUITE 102
BURLINGAME
CA
94010
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
3.88
2019-01-28
4
A
0
210000
0.00
A
2029-01-28
Common Stock
210000
210000
D
The underlying shares subject to the option vest and become exercisable as to twenty-five percent (25%) of the shares subject to the option on January 28, 2020, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Leiv Lea, as Attorney-in-Fact for Mehrdad Mobasher
2019-01-30